Peer-reviewedCC BYInternational journal of molecular sciences
Minocycline-Mediated Inhibition of Microglial Activation in Neuroinflammation-Related Neuropsychiatric Disorders: Preclinical Promise and Clinical Limitations
Related
- Therapeutic targeting of TCF/LEF transcription factors in neuropsychiatric disorders via Wnt/β-catenin signaling
- CX3CL1/CX3CR1-Mediated Neuron–Microglia Crosstalk Contributes to Methamphetamine-Induced Neuroinflammation and Cognitive Impairment
- Neuroimmune Interactions in Chronic Pain and Neuroinflammation: Peripheral Nerve Injury, Neuroimmune Mechanisms, and Therapeutic Recovery
- Integrated re-analysis of bulk and single-cell transcriptomic data reveals limited ferroptosis and neuroinflammation signatures after sevoflurane exposure in the aged rat hippocampus and human prefrontal cortex cells
- Loss of microbial diversity from human–microbe coevolution: immune, epigenetic, and enteric nervous system mechanisms linking dysbiosis to neuropsychiatric and neurodegenerative diseases
BibTeX
@article{anon2026minocyclinemediated,
title = {{Minocycline-Mediated Inhibition of Microglial Activation in Neuroinflammation-Related Neuropsychiatric Disorders: Preclinical Promise and Clinical Limitations}},
journal = {International journal of molecular sciences},
year = {2026},
month = sep,
url = {https://europepmc.org/article/PMC/PMC13665158},
note = {CC BY},
}
RIS
TY - JOUR
TI - Minocycline-Mediated Inhibition of Microglial Activation in Neuroinflammation-Related Neuropsychiatric Disorders: Preclinical Promise and Clinical Limitations
PY - 2026
DA - 2026/09/24
JO - International journal of molecular sciences
UR - https://europepmc.org/article/PMC/PMC13665158
SN - 1422-0067
ER -